.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
QuintilesIMS
US Department of Justice
McKesson
Cerilliant
Dow
UBS
Baxter
Daiichi Sankyo

Generated: June 27, 2017

DrugPatentWatch Database Preview

ESKALITH CR Drug Profile

« Back to Dashboard

Which patents cover Eskalith Cr, and when can generic versions of Eskalith Cr launch?

Eskalith Cr is a drug marketed by Jds Pharms and is included in one NDA.

The generic ingredient in ESKALITH CR is lithium carbonate. There are fifteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.

Summary for Tradename: ESKALITH CR

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list56
Clinical Trials: see list3
Patent Applications: see list80
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ESKALITH CR at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jds Pharms
ESKALITH CR
lithium carbonate
TABLET, EXTENDED RELEASE;ORAL018152-001Mar 29, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Department of Justice
Merck
Healthtrust
Cipla
Accenture
Argus Health
AstraZeneca
Covington
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot